Back

Levosimendan administration and survival in patients receiving mechanical circulatory support: insights from an unselected real-world cohort

29 August 2026 (10:55 - 11:05)
Organised by: Logo
Congress Presentation Part of: From myocardial injury to remodelling: new biomarkers and therapeutic windows Cardiogenic Shock ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Emre Ozdemircelik

(Germany)

5 More presentations in this session

Presentation thumbnail
Peak high-sensitivity troponin-T concentration and risk of heart failure in patients with suspected acute coronary syndrome
Doctor P. Ahle Erichsen (Gentofte, DK)
Abstract Slides
Presentation thumbnail
Endomyocardial biopsy-based inflammatory phenotypes predict outcomes in virus-negative inflammatory cardiomyopathy
Doctor C. Baumeier (Berlin, DE)
Abstract Slides
Presentation thumbnail
A newborn screening–enabled therapeutic window in late-onset fabry disease: long-term divergent remodeling trajectories with early-stage treatment
Doctor K. Sung (Taipei, TW)
Abstract Slides
Presentation thumbnail
Low QRS voltages and risk stratification in acute myocarditis : insights from the AMPHIBIA registry
Mr F. Ravera (Paris, FR)
Abstract Slides
Presentation thumbnail
Titin expression in peripheral monocytes as a biomarker of left ventricular dysfunction in acute myocarditis.
Doctor S. Maragkoudakis (Chania, GR)
Abstract Slides

Access the full session

Session thumbnail
From myocardial injury to remodelling: new biomarkers and therapeutic windows
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 10:55 CET
You may be interested in
thumbnail
Congress Presentation
Experience with levosimendan in cardiogenic shock: inotrope weaning and clinical outcomes in a real-world cohort
21 March 2026
thumbnail
Congress Presentation
Impact of mechanical circulatory support devices on mortality in a prospective single center registry of patients with cardiac arrest
21 May 2023
thumbnail
Congress Presentation
Vasoactive medication requirements in the first 24 hours of cardiogenic shock: association with mortality and mechanical circulatory support
27 August 2023
thumbnail
Congress Presentation
Intermittent outpatient administration of levosimendan improves right ventricular-pulmonary arterial coupling in ambulatory patients with advanced heart failure
11 December 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources